Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global In-Situ Hybridization Market by Type (Radioactive isotopes, Non-radioactive labels), By Application (Cancer Diagnosis, Immunology, Neuroscience, Cytology, Infectious Diseases) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global In-Situ Hybridization Market by Type (Radioactive isotopes, Non-radioactive labels), By Application (Cancer Diagnosis, Immunology, Neuroscience, Cytology, Infectious Diseases) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 137775 3300 Pharma & Healthcare 377 230 Pages 4.7 (36)

Market Overview:

The global in situ hybridization market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for in situ hybridization techniques for cancer diagnosis, immunology, neuroscience, cytology and infectious diseases applications. Additionally, the increasing use of non-radioactive labels in in situ hybridization is also contributing to the growth of this market. However, factors such as high cost and lack of skilled professionals are restraining the growth of this market. On the basis of type, radioactive isotopes held a major share of the global in situ hybridization market in 2017. This can be attributed to their ability to provide high sensitivity and specificity results compared with other types of labels used for in situ hybridization techniques.

Global In-Situ Hybridization Industry Outlook

Product Definition:

A technique used to detect the presence of a particular sequence of DNA in a tissue section or cell sample. The sequence is first identified by PCR and then labeled with a fluorescent probe. The probe is then applied to the tissue section or cell sample, where it will hybridize (bind) to any complementary sequences that are present.

Radioactive isotopes:

Isotopes are the different forms of a particular chemical element such as lead, uranium, gold, etc. The most commonly used radioactive isotopes in molecular diagnostics are radium-223 and iodine-123 which is used to diagnose thyroid cancer. Radioactive isotopes can be produced artificially by bombarding other elements with high energy particles or they can be found in nature in the form of uranium and thorium.

Non-radioactive labels:

Non-radioactive labels are used in the detection of cell types by In-Situ Hybridization (ISH). These labels are attached to the cells and then analyzed with a microscope. The most commonly used label is fluorescent dyes that can be detected with an antibody. Fluorescent dyes have been commercialized for different purposes such as biological stains, flow cytometry, and cellular imaging among others.

Application Insights:

The cancer diagnosis segment dominated the global in-situ hybridization market in 2017. This is owing to the rising prevalence of cancer and increasing demand for sensitive, specific and rapid diagnostic methods. In addition, a rise in R&D investments by various companies for developing new products related to this field is expected to boost growth over the forecast period.

For instance, last year Amgen launched AndroGel 1.5%, a testosterone gel that is designed for men who have had surgery or cannot take oral medication due to liver problems caused due to their high concentration of sex hormone binding globulin (SHBG). Similarly, CisGenomics has developed a blood test that can detect mutations associated with colorectal cancer called PanCancer Test which provides results within two weeks instead of three months as compared with other tests available in the market today. Such initiatives by key players are expected fuel growth over the forecast period  (2017-2030).

Regional Analysis:

North America dominated the global in-situ hybridization market with a share of 40.0% in 2017. This is owing to the presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and increasing demand for cost-effective diagnosis methods for various diseases. Moreover, rise in R&D investment by government organizations and pharmaceutical companies is expected to drive this growth over the forecast period.

Asia Pacific region is anticipated to witness lucrative CAGR over the forecast period due to factors such as rising prevalence of cancer and infectious diseases coupled with growing medical tourism industry resulting from economic development in Asian countries such as India & China & Malaysia etc.

Growth Factors:

  • Increasing demand for In-Situ Hybridization in the field of life sciences research
  • Rising prevalence of cancer and other diseases
  • Growing number of hybridization techniques being developed and commercialized
  • Technological advancements in In-Situ Hybridization instruments and probes
  • Increasing use of In-Situ Hybridization in drug discovery and development

Scope Of The Report

Report Attributes

Report Details

Report Title

In-Situ Hybridization Market Research Report

By Type

Radioactive isotopes, Non-radioactive labels

By Application

Cancer Diagnosis, Immunology, Neuroscience, Cytology, Infectious Diseases

By Companies

Abbott Laboratories, F. Hoffmann-La Roche, Leica Biosystems Nussloch, Agilent Technologies, Thermo Fisher Scientific, Merck, PerkinElmer, Exiqon A/S, BioGenex Laboratories, Advanced Cell Diagnostics, Bio SB

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global In-Situ Hybridization Market Report Segments:

The global In-Situ Hybridization market is segmented on the basis of:


Radioactive isotopes, Non-radioactive labels

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Cancer Diagnosis, Immunology, Neuroscience, Cytology, Infectious Diseases

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Abbott Laboratories
  2. F. Hoffmann-La Roche
  3. Leica Biosystems Nussloch
  4. Agilent Technologies
  5. Thermo Fisher Scientific
  6. Merck
  7. PerkinElmer
  8. Exiqon A/S
  9. BioGenex Laboratories
  10. Advanced Cell Diagnostics
  11. Bio SB

Global In-Situ Hybridization Market Overview

Highlights of The In-Situ Hybridization Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Radioactive isotopes
    2. Non-radioactive labels
  1. By Application:

    1. Cancer Diagnosis
    2. Immunology
    3. Neuroscience
    4. Cytology
    5. Infectious Diseases
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the In-Situ Hybridization Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global In-Situ Hybridization Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

In-situ hybridization is a method of detecting and identifying nucleic acids in situ. Nucleic acids are isolated from a sample, labeled with a detectable marker, and then placed into contact with the probe molecule. The probe will hybridize to the target nucleic acid sequence and be detected by an assay system.

Some of the key players operating in the in-situ hybridization market are Abbott Laboratories, F. Hoffmann-La Roche, Leica Biosystems Nussloch, Agilent Technologies, Thermo Fisher Scientific, Merck, PerkinElmer, Exiqon A/S, BioGenex Laboratories, Advanced Cell Diagnostics, Bio SB.

The in-situ hybridization market is expected to register a CAGR of 7.5%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. In-Situ Hybridization Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. In-Situ Hybridization Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. In-Situ Hybridization Market - Supply Chain
   4.5. Global In-Situ Hybridization Market Forecast
      4.5.1. In-Situ Hybridization Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. In-Situ Hybridization Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. In-Situ Hybridization Market Absolute $ Opportunity

5. Global In-Situ Hybridization Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. In-Situ Hybridization Market Size and Volume Forecast by Type
      5.3.1. Radioactive isotopes
      5.3.2. Non-radioactive labels
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global In-Situ Hybridization Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. In-Situ Hybridization Market Size and Volume Forecast by Application
      6.3.1. Cancer Diagnosis
      6.3.2. Immunology
      6.3.3. Neuroscience
      6.3.4. Cytology
      6.3.5. Infectious Diseases
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global In-Situ Hybridization Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. In-Situ Hybridization Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global In-Situ Hybridization Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. In-Situ Hybridization Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global In-Situ Hybridization Demand Share Forecast, 2019-2029

9. North America In-Situ Hybridization Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America In-Situ Hybridization Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America In-Situ Hybridization Market Size and Volume Forecast by Application
      9.4.1. Cancer Diagnosis
      9.4.2. Immunology
      9.4.3. Neuroscience
      9.4.4. Cytology
      9.4.5. Infectious Diseases
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America In-Situ Hybridization Market Size and Volume Forecast by Type
      9.7.1. Radioactive isotopes
      9.7.2. Non-radioactive labels
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America In-Situ Hybridization Demand Share Forecast, 2019-2029

10. Latin America In-Situ Hybridization Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America In-Situ Hybridization Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America In-Situ Hybridization Market Size and Volume Forecast by Application
      10.4.1. Cancer Diagnosis
      10.4.2. Immunology
      10.4.3. Neuroscience
      10.4.4. Cytology
      10.4.5. Infectious Diseases
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America In-Situ Hybridization Market Size and Volume Forecast by Type
      10.7.1. Radioactive isotopes
      10.7.2. Non-radioactive labels
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America In-Situ Hybridization Demand Share Forecast, 2019-2029

11. Europe In-Situ Hybridization Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe In-Situ Hybridization Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe In-Situ Hybridization Market Size and Volume Forecast by Application
      11.4.1. Cancer Diagnosis
      11.4.2. Immunology
      11.4.3. Neuroscience
      11.4.4. Cytology
      11.4.5. Infectious Diseases
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe In-Situ Hybridization Market Size and Volume Forecast by Type
      11.7.1. Radioactive isotopes
      11.7.2. Non-radioactive labels
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe In-Situ Hybridization Demand Share, 2019-2029

12. Asia Pacific In-Situ Hybridization Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific In-Situ Hybridization Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific In-Situ Hybridization Market Size and Volume Forecast by Application
      12.4.1. Cancer Diagnosis
      12.4.2. Immunology
      12.4.3. Neuroscience
      12.4.4. Cytology
      12.4.5. Infectious Diseases
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific In-Situ Hybridization Market Size and Volume Forecast by Type
      12.7.1. Radioactive isotopes
      12.7.2. Non-radioactive labels
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific In-Situ Hybridization Demand Share, 2019-2029

13. Middle East & Africa In-Situ Hybridization Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa In-Situ Hybridization Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa In-Situ Hybridization Market Size and Volume Forecast by Application
      13.4.1. Cancer Diagnosis
      13.4.2. Immunology
      13.4.3. Neuroscience
      13.4.4. Cytology
      13.4.5. Infectious Diseases
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa In-Situ Hybridization Market Size and Volume Forecast by Type
      13.7.1. Radioactive isotopes
      13.7.2. Non-radioactive labels
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa In-Situ Hybridization Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global In-Situ Hybridization Market: Market Share Analysis
   14.2. In-Situ Hybridization Distributors and Customers
   14.3. In-Situ Hybridization Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Abbott Laboratories Overview Financials Developments Strategic Outlook
      14.4.2. F. Hoffmann-La Roche Overview Financials Developments Strategic Outlook
      14.4.3. Leica Biosystems Nussloch Overview Financials Developments Strategic Outlook
      14.4.4. Agilent Technologies Overview Financials Developments Strategic Outlook
      14.4.5. Thermo Fisher Scientific Overview Financials Developments Strategic Outlook
      14.4.6. Merck Overview Financials Developments Strategic Outlook
      14.4.7. PerkinElmer Overview Financials Developments Strategic Outlook
      14.4.8. Exiqon A/S Overview Financials Developments Strategic Outlook
      14.4.9. BioGenex Laboratories Overview Financials Developments Strategic Outlook
      14.4.10. Advanced Cell Diagnostics Overview Financials Developments Strategic Outlook
      14.4.11. Bio SB Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us